3-chloro-4-(2-(3-(2-cyclopropyl-1H-imidazol-1-yl)phenoxy)ethoxy)benzonitrile

ID: ALA4446351

PubChem CID: 138471318

Max Phase: Preclinical

Molecular Formula: C21H18ClN3O2

Molecular Weight: 379.85

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  N#Cc1ccc(OCCOc2cccc(-n3ccnc3C3CC3)c2)c(Cl)c1

Standard InChI:  InChI=1S/C21H18ClN3O2/c22-19-12-15(14-23)4-7-20(19)27-11-10-26-18-3-1-2-17(13-18)25-9-8-24-21(25)16-5-6-16/h1-4,7-9,12-13,16H,5-6,10-11H2

Standard InChI Key:  MNEOWBDGBJBREB-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
   29.5743   -2.8890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5732   -3.7086    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.2812   -4.1175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.9909   -3.7081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.9880   -2.8854    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.2794   -2.4802    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.6942   -2.4742    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   32.4034   -2.8801    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.1096   -2.4688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.8188   -2.8748    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.5250   -2.4635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.2303   -2.8712    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.9359   -2.4606    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.9333   -1.6425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.2191   -1.2368    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.5163   -1.6497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8705   -2.4764    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.7849   -1.6637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9855   -1.4940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.5770   -2.2018    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.1241   -2.8089    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9544   -3.6083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.6395   -1.2347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.3452   -0.8225    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.2314   -3.6884    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   27.4058   -4.2129    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.2051   -4.3826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 17  1  0
  1 17  1  0
 21 22  1  0
 23 24  3  0
 14 23  1  0
 12 25  1  0
 26 22  1  0
 27 26  1  0
 22 27  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4446351

    ---

Associated Targets(Human)

ICMT Tchem Isoprenylcysteine carboxyl methyltransferase (596 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 379.85Molecular Weight (Monoisotopic): 379.1088AlogP: 4.73#Rotatable Bonds: 7
Polar Surface Area: 60.07Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 6.34CX LogP: 4.59CX LogD: 4.55
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.56Np Likeness Score: -1.80

References

1. Kargbo RB..  (2019)  Treatment of Cancers by Inhibition of Isoprenylcysteine Carboxyl Methyltransferase.,  10  (7): [PMID:31312402] [10.1021/acsmedchemlett.9b00269]

Source